BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu R, Liu S, Anwaier G, Wang Q, Shen W, Shen Q, Qi R. Formulation and intestinal absorption of naringenin loaded nanostructured lipid carrier and its inhibitory effects on nonalcoholic fatty liver disease. Nanomedicine 2021;32:102310. [PMID: 33184021 DOI: 10.1016/j.nano.2020.102310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Alotaibi BS, Pervaiz F, Buabeid M, Ashames A, Fahelelbom KM, Siddique S, Shoukat H, Rehman S, Noreen S, Murtaza G. Nanostructured lipid carriers based suppository for enhanced rectal absorption of ondansetron: In vitro and in vivo evaluations. Arabian Journal of Chemistry 2021;14:103426. [DOI: 10.1016/j.arabjc.2021.103426] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Katopodi A, Detsi A. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers of natural products as promising systems for their bioactivity enhancement: The case of essential oils and flavonoids. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2021;630:127529. [DOI: 10.1016/j.colsurfa.2021.127529] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
3 Abou Assi R, Abdulbaqi IM, Siok Yee C. The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update. Pharmaceuticals (Basel) 2021;14:215. [PMID: 33806527 DOI: 10.3390/ph14030215] [Reference Citation Analysis]
4 Zhang M, Zhu S, Yang W, Huang Q, Ho CT. The biological fate and bioefficacy of citrus flavonoids: bioavailability, biotransformation, and delivery systems. Food Funct 2021;12:3307-23. [PMID: 33735339 DOI: 10.1039/d0fo03403g] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]